Inovalon Investor Conference Presentation Deck
Pharmaceutical Platform Offering Example
For clients utilizing Inovalon's Outcomes-Based Contracting (OBC) Platform: payers benefit from reductions in overall costs;
patients benefit from improved outcomes; providers benefit from support for their patients; and pharmaceutical
manufacturers benefit from greater unit sales of their medications.
While the cost of a
medication by itself may be
more expensive than an
alternative or predecessor in
the market, deep analysis of
optimal patient identification
and data-driven enablement
of patient-specific monitoring
and intervention support can
result in significant overall
cost reductions while also
achieving superior clinical
quality outcomes.
Medication
Cost
Additional
Medical
Costs
Market Standard
State
Total Healthcare Cost Reduction
Achieved with
Inovalon's OBC Platform
Inovalon OBC
Platform State
32.3%
Total Healthcare
Cost Reduction¹
1 Study performed by Inovalon pharmaceutical manufacturer client. 134,599 patients on standard care vs. 2,122 patients on specified medication showing opportunity for PPPY improvement in setting of specific medication and adherence. Illustrative.
INOV Investor Presentation (1.14.20) v1.0.0
41View entire presentation